Chromosomal Abnormalities
6
1
1
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disorders
Chromosomal Abnormalities in Patients With Congenital Heart Disease at Assiut University Children's Hospital
Prevalence of Translocation Phenotyping in Children With Down Syndrome and Their Parents
Preimplantation Genetic Screening in Women of Advanced Maternal Age
Genetic Analysis of Fraser Syndrome and Fryns Syndrome
Chromosomal Analysis of Single Cells in Human Embryos